LONG BEACH, Calif., Jan. 23, 2017 -- Molina Healthcare, Inc. (NYSE:MOH) today announced that it will report its earnings for the fourth quarter and year ended December 31, 2016, after the market closes on Wednesday, February 15, 2017. The Company’s management will host a conference call and webcast to discuss the earnings release at 5:00 p.m. Eastern time on the same day.
The number to call for the interactive teleconference is (212) 231-2922. A telephonic replay of the conference call will be available from 7:00 p.m. Eastern time on Wednesday, February 15, 2017, through 6:00 p.m. on Thursday, February 16, 2017, by dialing (800) 633-8284 and entering confirmation number 21842012.
A live broadcast of Molina Healthcare’s conference call will be available on the Company’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.
About Molina Healthcare, Inc.
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed health care services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through our locally operated health plans in 12 states across the nation and in the Commonwealth of Puerto Rico, Molina serves approximately 4.2 million members. Dr. C. David Molina founded our company in 1980 as a provider organization serving low-income families in Southern California. Today, we continue his mission of providing high quality and cost-effective health care to those who need it most. For more information about Molina Healthcare, please visit our website at
molinahealthcare.com.
Contact: Juan José Orellana Investor Relations (562) 435-3666


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



